CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 72 filers reported holding CULLINAN ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,066,101 | -80.3% | 195,839 | -76.1% | 0.03% | -82.7% |
| Q2 2022 | $10,494,000 | +111.0% | 818,572 | +72.3% | 0.16% | +100.0% |
| Q1 2022 | $4,974,000 | -32.1% | 475,058 | 0.0% | 0.08% | -22.9% |
| Q4 2021 | $7,330,000 | -31.6% | 475,058 | 0.0% | 0.10% | -40.0% |
| Q3 2021 | $10,722,000 | -25.8% | 475,058 | -15.4% | 0.18% | -34.9% |
| Q2 2021 | $14,451,000 | -36.1% | 561,206 | +3.4% | 0.27% | -46.4% |
| Q1 2021 | $22,623,000 | – | 542,912 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |